BioTech
KRAS, the ideal cancer drug target that became ‘undruggable,’ takes on a new glow
On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. KRAS, one of the most common
Angus Chen and Bree Iskandar
August 30, 2023